Skip to main content
. 2018 Aug 14;24(12):1253–1263. doi: 10.1111/cns.13051

Table 2.

Summary of the 18 potential AD drug target genes identified in this study

Gene symbol Protein name Gene ID P‐value Reported or NOT
RELN Reelin 5649 0.000546 Reported
DNMBP Dynamin binding protein 23268 0.003415 Reported
APOD Apolipoprotein D 347 0.003759 Reported
LEP Leptin 3952 0.008264 Reported
HLA‐B Major histocompatibility complex, class I, B 3106 0.011278 Reported
C1QB Complement C1q B chain 713 0.015038 Reported
HSPG2 Heparan sulfate proteoglycan 2 3339 0.018797 Reported
MTTP Microsomal triglyceride transfer protein 4547 0.022556 NOT
IL−10 Interleukin 10 3586 0.024793 Reported
TF Transferrin 7018 0.026316 Reported
NOS1AP Nitric oxide synthase 1 adaptor protein 9722 0.027164 NOT
A2M Alpha−2‐macroglobulin 2 0.030075 Reported
NEK4 NIMA related kinase 4 6787 0.033058 NOT
CD86 CD86 molecule 942 0.033835 Reported
PIK3C2A Phosphatidylinositol−4‐phosphate 3‐kinase catalytic subunit type 2 alpha 5286 0.041353 NOT
ADAM12 ADAM metallopeptidase domain 12 8038 0.044259 Reported
TARBP1 TAR (HIV−1) RNA binding protein 1 6894 0.045113 NOT
GABRG2 Gamma‐aminobutyric acid type A receptor gamma2 subunit 2566 0.048872 Reported